SEVILLE, Spain — Home monitoring of neovascular age-related macular degeneration, an interesting concept with many potential benefits, has entered the retina space in the U.S. with the Scanly Home OCT monitoring program from Notal Vision.
But are patients, physicians and health care systems ready for this paradigm shift in the management of neovascular AMD? Two specialists offered their perspectives at the Congress on Controversies in Ophthalmology.
Home OCT has the potential to improve outcomes in neovascular AMD, providing personalized patient care, according to Nancy M. Holekamp, MD.